Cite
HARVARD Citation
Bienz, M. et al. (2023). A Retrospective Review of the Clinical Outcomes of Trastuzumab Deruxtecan (T-DXd) for the Treatment of Advanced HER2-positive Breast Cancer at the Mount Vernon Cancer Centre. Clinical oncology. 35 (6), pp. e414-. [Online].